|
|||||
|
|
Antitumor agents 287. Substituted 4-amino-2H-pyran-2-one (APO) analogs reveal a new scaffold from neo-tanshinlactone with in vitro anticancer activity |
|
| Authors: | Dong Yizhou Nakagawa-Goto Kyoko Lai Chin-Yu Morris-Natschke Susan L Bastow Kenneth F Lee Kuo-Hsiung |
| Institution: | a Natural Products Research Laboratories, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599-7568, USA b Division of Medicinal Chemistry and Natural Products, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599-7568, USA c Chinese Medicine Research and Development Center, China Medical University and Hospital, Taichung, Taiwan |
| Abstract: | 4-Amino-2H-benzoh]chromen-2-one (ABO) and 4-amino-7,8,9,10-tetrahydro-2H-benzoh]chromen-2-one (ATBO) analogs were found to be significant in vitro anticancer agents in our previous research. Our continuing study has now discovered a new simplified (monocyclic rather than tricyclic) class of cytotoxic agents, 4-amino-2H-pyran-2-one (APO) analogs. By incorporating various substituents on the pyranone ring, we have established preliminary structure-activity relationships (SAR). Analogs 19, 20, 23, and 26-30 displayed significant tumor cell growth inhibitory activity in vitro. The most active compound 27 exhibited ED50 values of 0.059-0.090 μM. |
| Keywords: | 4-Amino-2H-pyran-2-one (APO) analogs Neo-tanshinlactone Cytotoxicity |
| 本文献已被 ScienceDirect PubMed 等数据库收录！ | |